Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1994 May 15;117(5):583-8.
doi: 10.1016/s0002-9394(14)70063-7.

Color contrast sensitivity and pattern electroretinographic findings after diode and argon laser photocoagulation in diabetic retinopathy

Affiliations
Clinical Trial

Color contrast sensitivity and pattern electroretinographic findings after diode and argon laser photocoagulation in diabetic retinopathy

M R Ulbig et al. Am J Ophthalmol. .

Abstract

The retinal depth at which photocoagulation is maximal varies with wavelength. We compared visual function of eyes undergoing photocoagulation by the near-infrared diode laser to the argon green laser. We treated 14 patients with diabetic retinopathy requiring bilateral panretinal photocoagulation with the diode laser on the right eye and the argon system on the left eye. Before and after treatment visual acuity, central and peripheral color contrast sensitivity, and pattern electroretinograms were recorded. No difference was noted in the clinical response or visual acuity outcome, but a tendency was observed for less decline in color contrast sensitivity and pattern electroretinogram recordings after diode laser photocoagulation. Although P values (.05 to .5) did not reach significance, a mean of 8.4 of 14 patients per test had better test results after diode laser treatment. Diode laser photocoagulation seems to be a viable alternative to argon laser treatment and may be a more gentle mode of treatment.

PubMed Disclaimer

Publication types

LinkOut - more resources